Objective: To determine the frequency, mortality, cost, and risk factors associated with readmission after index hospitalization with severe sepsis. Design: Observational cohort study of Healthcare Cost and Utilization Project data. Setting: All nonfederal hospitals in three U.S. states. Patients: Severe sepsis survivors (n = 43,452) in the first two quarters of 2011. Interventions: None. Measurements and Main Results: We measured readmission rates and the associated cost and mortality of readmissions in severe sepsis survivors. We used multivariable logistic regression to identify patient and hospitalization characteristics associated with readmission. Of 43,452 sepsis survivors, 26% required readmission within 30 days and 48% within 180 days. The cumulative mortality rate of sepsis survivors attributed to readmissions was 8%, and the estimated cost was over $1.1 billion. Among survivors, 25% required multiple readmissions within 180 days and accounted for 77% of all readmissions. Age younger than 80 years (odds ratio, 1.14; 95% CI, 1.08-1.21), black race (odds ratio, 1.18; 95% CI, 1.10-1.26), and Medicare or Medicaid payor status (odds ratio, 1.21; 95% CI, 1.13-1.30; odds ratio, 1.34; 95% CI, 1.23-1.46, respectively) were associated with greater odds of 30-day readmission while female gender was associated with reduced odds (odds ratio, 0.92; 95% CI, 0.87-0.96). Comorbidities including malignancy (odds ratio, 1.34; 95% CI, 1.24-1.45), collagen vascular disease (odds ratio, 1.30; 95% CI, 1.15-1.46), chronic kidney disease (odds ratio, 1.24; 95% CI, 1.18-1.31), liver disease (odds ratio, 1.22; 95% CI, 1.11-1.34), congestive heart failure (odds ratio, 1.14; 95% CI, 1.08-1.19), lung disease (odds ratio, 1.12; 95% CI, 1.06-1.18), and diabetes (odds ratio, 1.12; 95% CI, 1.07-1.17) were associated with greater odds of 30-day readmission. Index hospitalization characteristics including longer length of stay, discharge to a care facility, higher hospital annual severe sepsis case volume, and higher hospital sepsis mortality rate were also positively associated with readmission rates. Conclusion: The 30-day and 180-day readmissions are common in sepsis survivors with significant resultant cost and mortality. Patient sociodemographics and comorbidities as well as index hospitalization characteristics are associated with 30-day readmission rates. (Crit Care Med 2015; 43:738-746) 
H ospital readmissions are common and have far-reaching implications for patients and society (1) . Approximately 20% of discharged Medicare beneficiaries are rehospitalized within 30 days of discharge, whereas 34% are rehospitalized within 90 days (2) . Readmissions impact quality of life and represent a significant cost burden to the U.S. healthcare system with annual costs estimated to be $17 billion in Medicare recipients alone (2) . Hospital readmission within 30 days of discharge has been associated with substandard care during the index admission (3) and inadequate postdischarge care processes (4) . This has led to the assertion that a proportion of readmissions are avoidable although estimates of this proportion vary widely (5) . Accordingly, the Patient Protection and Affordable Care Act has mandated that hospitals reduce readmissions for heart failure, myocardial infarction, and pneumonia. Starting in 2013, the Center for Medicare and Medicaid Services began tying reimbursement rates for all diagnosis-related groups to the readmission rates for these common and costly diagnoses (2, 6) .
Similarly, severe sepsis is a disease of high prevalence and cost. Evaluation of Medicare claims shows an increasing prevalence of severe sepsis with over 1 million annual admissions (7) , whereas the total annual cost of sepsis admissions now exceeds $20 billion in the United States (8) . Approximately 850,000 Medicare patients survived admission for severe sepsis in 2008 (7) , representing a large population at risk of hospital readmission given large comorbidity burdens (9) and adverse cognitive and functional sequelae (10) . Despite the size and fragility of this population, little is known about its readmission rates or their associated cost and risk factors.
Quantifying the scope of readmissions in severe sepsis survivors and identifying risk factors may inform policy and facilitate identification of high risk-patients for future targeted intervention. Thus, we evaluated readmission patterns, potential risk factors, and cost after an index admission with severe sepsis in a large administrative database. The objectives of this study were to 1) quantify the frequency of 30-day readmissions in severe sepsis survivors, 2) identify associations between patient and/or index hospitalization characteristics and readmissions, and 3) determine whether readmissions are a frequent problem beyond 30 days from discharge and estimate the costs associated with these readmissions.
MATERIALS AND METHODS

Study Design/Data Source
We performed a retrospective cohort study of adults hospitalized with severe sepsis to nonfederal hospitals in California, Florida, and New York during the first two quarters of the calendar year 2011 using these states' Healthcare Cost and Utilization Project (HCUP) state inpatient databases (SID). These states were chosen because their large size and geographic heterogeneity enhance the generalizability of the study's findings and because their SIDs contain patient-level identifiers such that readmissions are traceable.
Severe Sepsis Cohort Identification
We identified all patients, 20 years old or older, who were admitted in quarter 1 (Q1) or quarter 2 (Q2) of 2011 and experienced severe sepsis and/or septic shock during this index admission. Index admissions were confined to Q1/Q2 to allow adequate time for a 180-day follow-up period. We defined this cohort by the presence of an International Classification of Disease, 9th Edition, Clinical Modification (ICD-9-CM) code for severe sepsis (995.92) or septic shock (785.52). This approach provides a highly specific severe sepsis cohort (11, 12) and, thus, a conservative estimate of severe sepsis survivors. Although this approach has been historically limited by sensitivity, recent data demonstrate that the use of explicit severe sepsis and septic shock codes is increasingly common (13) . We subsequently generated a severe sepsis survivor cohort by excluding patients who died during their index admission and those with missing data. Index hospitalizations that resulted in a transfer to another acute care hospital were counted as one admission rather than two episodes of care. In all cases of interhospital transfer, index hospital characteristics were attributed to the receiving hospital. Examination of a sample of the dataset revealed poor correlation between a discharge status of "transferred to another hospital" and a subsequent admission source of "transfer from another acute care hospital," suggesting a high rate of miscoding for these variables. Thus, to more comprehensively identify interhospital transfers, we considered any admission that occurred on the same calendar day as a discharge from a different hospital to be an interhospital transfer. If an individual had more than one admission for severe sepsis in Q1/Q2, the first was considered the index admission, whereas subsequent admissions were considered readmissions.
Outcomes
The primary outcome was readmission within 30 days of discharge from the index hospitalization. Secondary outcomes included readmission within 180 days of discharge, mortality associated with readmission, and costs associated with readmission.
Data Collection
The survivor cohort was analyzed for 180 days after the day of discharge as we hypothesized that severe sepsis survivors would be at risk for readmission beyond the 30-day window. Diagnoses, survival status, and charges associated with each readmission were captured. Readmission rates were calculated for 30-day intervals by dividing the number of survivors readmitted for the first time during the interval by the total survivor cohort. As our goal was to determine the percentage of the total sepsis survivor cohort (n = 43,425) who ultimately required readmission, we deliberately did not adjust the survivor cohort size to account for mortality during earlier intervals. The cumulative mortality rate attributed to readmissions was calculated for each interval by dividing deaths during readmission by the number of readmissions for each interval. The aggregate number of readmissions (initial and subsequent) was calculated for each time interval, and their principal diagnoses were used to categorize the cause for each readmission using the HCUP Clinical Classification Software (14) (15) (16) (17) . Cumulative costs for readmissions were calculated over the 180-day follow-up period by multiplying charge data from the SID dataset by hospital-specific HCUP cost-to-charge ratios. Patient-level characteristics including age, gender, race (black, non-Hispanic white, Hispanic, Asian/Pacific islander, native American, or other), payor (commercial, Medicare, Medicaid, dual eligible, or other), Charlson score (18), and Elixhauser comorbidities (19) were captured from index hospitalization records as were index hospitalization data, including hospital length of stay (LOS), discharge destination, and acute organ failure rates. Organ failure was determined by a previously published method using ICD-9-CM codes to identify acute derangements in seven different organ systems (9) . As there is substantial evidence that readmissions are common after admission for pneumonia (2, 20, 21) , we also captured the presence or absence of ICD-9-CM codes for pneumonia from the index admissions (Supplemental Table 1 , Supplemental Digital Content 1, http://links.lww.com/CCM/B167) to better understand the relative contribution that this diagnosis plays in severe sepsis readmissions and to determine if pneumonia is an independent risk factor for readmission among severe sepsis survivors. Finally, hospital-level characteristics including HCUP hospital type, annual severe sepsis case volume (categorized into tertiles: low, < 60 cases/yr; intermediate, 60-300; high, > 300), and annual severe sepsis mortality rate (categorized into quartiles: 1 = mortality < 27.3%, 2 = mortality 27.3-32.4%, 3 = mortality 32.5-38.2%, 4 = mortality > 38.2%) were also captured. The sepsis case volume tertile boundaries were chosen based on previous unpublished observations that severe sepsis mortality was influenced by these volume tertiles, whereas the sepsis mortality quartile boundaries were chosen such that 25% of the patient sample fell within each quartile.
We further divided the readmission cohort into those who required one or multiple readmissions to understand the patterns and characteristics of the multiple readmissions population. The number and cost of readmissions for each subcohort were calculated.
Sensitivity Analysis
To account for variations in hospital coding practice, we performed a sensitivity analysis using a previously validated approach for defining a severe sepsis cohort from administrative data. Martin et al (9) used a combination of ICD-9-CM codes for septicemia, bacteremia, and fungal infection and codes for acute organ failure and validated its accuracy. The approach used to define our primary cohort has been shown to have similar positive and negative predictive values to the Martin approach (11). We compared our primary cohort to a cohort using the Martin approach and a third cohort using the Martin approach and/or the explicit ICD-9-CM codes for severe sepsis or septic shock. To evaluate for potential differences in readmission patterns when sepsis was present at admission (POA) versus not POA, we compared readmission rates and associated risk factors between patients in these two groups.
Statistical Analysis
We compared differences between readmission cohorts with chi-square analysis or Student t test where appropriate. We used a manually fitted multivariable logistic regression to determine associations between patient and hospitalization characteristics and hospital readmission. Model construction began with patient demographics, and then, organ failures, comorbidities, and hospitalization characteristics were added one at a time.
After the addition of each variable, the model was analyzed to determine if existing variables were still significant and if the model's goodness-of-fit was affected according to the Akaike Information Criterion. Hospital-level clustering was controlled for using mixed effects modeling. Referent values for nondichotomous covariates in the regression models include non-Hispanic white race, commercial insurance, discharge to home, the lowest hospital case volume tertile, and the lowest hospital case mortality quartile. When age was examined as a continuous variable, it was found to have a nonlinear relationship with readmission and an inflection point near age 80 years above which the risk for readmission declined. Thus, age younger than 80 years was added as a dichotomous variable to the model. For simplicity, the Elixhauser comorbidities for Diabetes Mellitus and Diabetes Mellitus with Complications were combined into one variable as were lymphoma, solid tumor, and metastatic cancer. All presented odds ratios represent adjusted odds from the multivariable model. We used SAS version 9.3 (Cary, NC) for all analysis and considered a twosided α 0.05 as the threshold for statistical significance. The study was reviewed and approved by the Institutional Review Board at the Medical University of South Carolina.
RESULTS
Of 2,986,305 admissions to nonfederal hospitals in California, Florida, and New York, 84,575 were coded for severe sepsis (995.92) and/or septic shock (785.52) in Q1/Q2 of 2011 ( Fig. 1) . Of these, there were 43,452 index admissions which met criteria for the severe sepsis survivor cohort. Over the 180-day follow-up period, 20,907 were readmitted resulting in 3,678 deaths (18%). Table 1 presents patient and index hospitalization characteristics of the entire survivor cohort and of the readmission and no-readmission subgroups.
Readmission Rates, Mortality, and Cost
Of the 43,452 severe sepsis survivors, 26% were readmitted within 30 days of discharge and 4% died while readmitted during this time frame ( Fig. 2A) . By 180 days, 48% of sepsis survivors had been readmitted and 8% of the original survivor cohort had died during readmission. The cumulative number of readmissions increased from 13,790 within 30 days of discharge to 43,443 admissions within 180 days of discharge which cost an estimated $366 million and $1.1 billion, respectively (Fig. 2B) . The mean cost of each readmission was $25,505 (sd, $38,765). Sepsis was the most common cause of readmission (22%) although the dataset lacked sufficient granularity to determine if these were related to unresolved sepsis or to new occurrences of sepsis.
Patient and Index Admission Characteristics Associated With Readmission
Multivariable logistic regression identified associations between patient/hospitalization characteristics and 30-day readmissions ( Table 2) . Having an age younger than 80 years was associated with increased chance of readmissions (adjusted odds ratio [aOR], 1.14; 95% CI, 1.08-1.21) while female gender was associated with a reduced chance (aOR, 0.92; 95% CI, 0.87-0.96). Alternative age cutoffs were examined to determine if a more complex association between age and readmission risk exists. In the age younger than 80-year population, declining age did not protect against 30-day readmissions until the threshold of 50 years at which point younger patients were associated with lower odds of readmission (data not shown). Black race was associated with an 18% increased odds of readmission (aOR, 1.18; 95% CI, 1.10-1.26) compared with white race. Having Medicare or Medicaid as primary payor were both associated with increased odds of readmission (aOR, 1.21; 95% CI, 1.13-1. 30 Hospital LOS greater than the survivor cohort median (10 d) was associated with a 50% greater risk of readmission (aOR, 1.50; 95% CI, 1.43-1.57). Discharge destination also predicted readmission as survivors who were discharged to a care facility were 48% more likely to be readmitted than those who were discharged to home (aOR, 1.48; 95% CI, 1.40-1.56). Conversely, survivors discharged to hospice care were at low risk of readmission (aOR, 0.17; 95% CI, 0.13-0.21) and were more likely to be above age 80 years (49% vs 30%; p < 0.0001). For each increase in annual sepsis case volume tertile, the risk of readmission increased (aOR, 1.07; 95% CI, 1.03-1.12). Additionally, increased hospital sepsis mortality rates were associated with more readmissions (aOR, 1.04; 95% CI, 1.02-1.07 for each increase in quartile). Not-for-profit status and urban/ rural designation were not associated with readmission risk in the multivariate model (data not shown).
During model development, we included variables for acute respiratory failure, shock, acute renal failure, acute hepatic injury, CNS dysfunction, hematologic dysfunction, and metabolic acidosis (9) . In early models, shock and acute renal failure had modest associations with readmission (data not shown); however, these associations lost significance after the addition of comorbidities to the model. The diagnosis of pneumonia was also not predictive in the multivariate model (data not shown).
Sensitivity Analysis
The Martin approach yielded a severe sepsis survivor cohort of 57,618 patients, whereas the combination of the Martin approach and the explicit codes for severe sepsis and septic shock yielded a cohort of 69,490 patients. The 30-day readmission rate for each cohort was 24.5% and 25.0%, respectively.
The multivariate logistic regression model demonstrated odds ratios similar to the primary cohort for each covariate (Supplemental Table 2 , Supplemental Digital Content 1, http://links. lww.com/CCM/B167). Only the sepsis case volume covariate lost its association with readmission in the Martin cohort; however, this association was retained in the combined cohort.
Sepsis was POA in a majority of our cases and accounted for 82.7% (n = 35,994) of the sepsis survivor cohort. Readmission trends were similar for patients with sepsis POA versus not POA (Supplemental Fig. 1 1, http://links.lww.com/CCM/B167). Covariates associated with readmission and their odds ratios were similar between patients with sepsis POA and not POA (data not shown).
, Supplemental Digital Content
A Minority of Survivors Represent a Disproportionate Number of Readmissions
Of the 43,425 survivors, 9,882 survivors (22.7%) were readmitted only once during the 180-day follow-up period, whereas 11,025 survivors (25.4%) were readmitted two or more times. Those with multiple readmissions accounted for 33,561 readmissions (77.3%) with a cumulative cost of $877.6 million (78.2% of all readmission costs).
Multivariable logistic regression was used to compare severe sepsis survivors who went on to experience one readmission with survivors who went on to experience multiple readmissions to determine characteristics associated with the risk of multiple readmissions ( Table 3 ). The parsimonious model closely resembled the model which predicted any readmission in survivors (Table 2) although patient covariates such as gender, lung disease, malignancy, and liver disease; hospitalization characteristics including discharge to care facility; and hospital characteristics including sepsis case volume and sepsis mortality were not associated with multiple readmissions.
DISCUSSION
Readmission after hospitalization with severe sepsis is common and associated with significant mortality and cost. These data demonstrate that almost half of all severe sepsis survivors require readmission within 6 months of discharge with the majority of readmissions occurring within the first 30 days. If these results were extrapolated to the entire U.S. population, severe sepsis survivors would annually experience over 91,300 readmissions within 30 days and over 171,300 readmissions within 6 months resulting in 14,200 and 30,100 in-hospital deaths and $3 billion and $9 billion in cost, respectively. The most common cause for readmission throughout the followup period was sepsis. Several patient characteristics were associated with the risk of 30-day readmission, including age, race, gender, insurance status, and comorbidities. Longer LOS and discharge destination to a care facility as well as higher hospital-level sepsis case volume and sepsis mortality rates were also associated with the need for readmission. Acute organ failure during the index hospitalization did not increase the risk of readmission among survivors above the risks associated with the identified comorbidities. Additionally, although the 30-day readmission rate after hospitalization for pneumonia is an important quality metric for the Center for Medicare and Medicaid Services, these data demonstrate that early readmission is common after severe sepsis in general and is not unique to pneumonia. Finally, approximately one quarter of severe sepsis survivors are responsible for over three quarters of all readmissions and readmission-related costs at 6 months.
Readmissions impact patient quality of life, morbidity, and mortality and now hospital reimbursement. Thus, reliable strategies to identify patients at heightened risk for readmission are important tools for clinicians, administrators, and payors. These data suggest that severe sepsis survivors are more likely to be readmitted if they are male, are of black race, and have Medicare and/or Medicaid as their primary payor. These findings are consistent with readmission risk factors found in survivors of other conditions (2, 21) and may be partially explained by variations in access to care (22, 23) and health literacy (24) (25) (26) (27) . Our findings also suggest that severe sepsis survivors are less likely to be readmitted if they are older than 80 years. As increasing age, in general, leads to increased frailty, it is possible that this observed relationship has to do with palliative care-related decisions and subsequent readmission avoidance as has been reported previously (28, 29) . Our observation that survivors older than 80 years are more likely to be discharged to hospice supports this hypothesis. We speculated that acute organ failure would be associated with 30-day readmission risk due to the likelihood of diminished functional status in multiple organ failure survivors; however, in the multivariate model, acute organ failure was not predictive. One potential explanation for this observation is that the cohort of sepsis patients with the most severe organ failure are logically at greatest risk of death during the index hospitalization and thus not eligible for readmission. By design, our initial cohort was developed to investigate the risk of readmission among survivors of severe sepsis and thus represents a patient population with lower risk of death as compared with patients who died during the index hospitalization. Hence, comorbidity burden emerged as a more significant determinant for hospital readmission than acute organ failure. Severe sepsis patients commonly have substantial comorbidity burdens (9) , and the comorbidities that are associated with readmission in the current study are also associated with frequent hospitalizations (30) (31) (32) (33) (34) (35) (36) (37) (38) . Thus, many severe sepsis survivors are at risk for being "hospital-dependent" patients (39) and have recently been shown to have greater need of healthcare facilities than nonsepsis survivors (40) . Our observation that shock and acute renal failure were modestly associated with readmission before, but not after, the addition of comorbidities to the model suggests that comorbidity burden is the stronger determinant and is likely to be a more reliable component of readmission risk prediction tools.
Although there is evidence that hospital case volume is inversely related to severe sepsis mortality (41) , it appears to have a modest direct association with readmissions. A common assertion used to explain the volume-mortality relationships in critical illness is that high-volume centers possess greater expertise and resources (42, 43) . As readmission rates are partly attributed to the quality of care during the index admission (3), it may be expected that index hospitalization at high-volume centers would associate with less readmissions. The opposite association that we observed could have several explanations. First, the inability to adequately control for severity of illness in ICU patients in administrative datasets introduces the possibility of confounding. However, our findings notably persisted while simultaneously controlling for age, comorbidities, and the presence of acute organ failure. Second, the reduced mortality rates at high-volume centers result in a larger pool of sepsis survivors vulnerable to readmission. Inverse relationships between mortality and readmission rates have been described in other conditions (44); thus, it is possible that high-volume hospitals lead to more readmissions because they save more patients from death. To account for this, we controlled for index hospital sepsis mortality rate and, surprisingly, found that as mortality increased so, too, did readmission rates. Although this may suggest that inadequate risk adjustment exists, other explanations including differences in peridischarge care practices or differences in patient socioeconomic status between high-volume and low-volume centers cannot be excluded. Finally, better-resourced, high-volume hospitals are more likely to receive interhospital transfers than low-volume hospitals, and the distance between transferring and receiving hospitals can be substantial (45) . This may lead to fragmented postdischarge care and subsequent readmission among survivors who were transferred to high-volume hospitals with severe sepsis and then return home for follow-up care.
These data demonstrate that a small proportion of severe sepsis survivors are responsible for a disproportionately large share of readmissions. The characteristics associated with increased odds of multiple readmissions were similar but not identical to those for a single readmission. Specifically, black race, Medicare/Medicaid status, and comorbidities were associated with multiple readmission. We speculate that related factors including health literacy, chronic disease management skills, social support, and other factors not accessible via administrative data may be important determinants to multiple readmissions and represent significant hurdles to readmission prevention. Conversely, we hypothesize that variables such as malignancy and discharge to a care facility may not be associated with multiple readmissions because their presence may influence survival during a subsequent readmission or be associated with future decisions to pursue palliation rather than multiple readmissions.
Our study has limitations. By using administrative data, our ability to risk adjust was limited, opening the possibility to previously discussed confounding. Also, as HCUP datasets are state specific, some readmissions may have occurred in states other than where the index admission occurred and thus not included. Furthermore, an unknown proportion of our identified index readmissions may actually have been readmissions from Q3/Q4 of 2010, which we are unable to discern due to changes in patient-level identifiers between calendar years. However, our approach has precedent in other analyses of readmissions (20) . The HCUP SIDs only contain information from inpatient hospitalizations; thus, outpatient data, including out-of-hospital mortality, are unavailable. This limited our ability to determine how many severe sepsis survivors were eligible for readmission during the follow-up period. As such, we calculated readmission rates using the entire survivor cohort as the denominator which may result in conservatively low readmission rates. Additionally, these states' datasets do not contain "ICU-care" codes, eliminating the ability to determine the impact of ICU requirement on readmission risk. Our observation that acute organ failure, a common reason for ICU admission, does not predict readmission in the multivariate model suggests that ICU requirement may not be associated with readmission risk, but we cannot conclude this with certainty. By design, we focused only on index admissions during the first two quarters of 2011. This allowed us to determine readmission rates and risk factors; however, it limited our ability to determine annual aggregate readmission data. Although seasonal variation in severe sepsis prevalence and mortality (46) further limited our ability to extrapolate our aggregate data for a full year, our selection of Q1 (higher prevalence and mortality) and Q2 (lower prevalence and mortality) increased the generalizability of these data. Our data were from three states in the northeast, southeast, and southwest. As hospital readmission rates vary by geography (47), generalizability to other areas may be limited, although our findings were consistent across each state and they contain nearly 25% of the U.S. population. Because we lacked data on peridischarge practices including transition of care to the outpatient setting, we are unable to determine the relative roles of these variables on readmission rates. Finally, the retrospective design of the study prohibited us from establishing causality for any of the risk factors identified in the study.
CONCLUSIONS
In conclusion, we found that 30-and 180-day readmissions are common in severe sepsis survivors and are associated with sociodemographics, comorbidities, discharge destination, hospital LOS, and index hospital characteristics. Readmissions after severe sepsis hospitalization result in substantial mortality and cost and are not exclusive to pneumonia. The majority of readmissions are generated by a minority of sepsis survivors who are of black race, are Medicare/Medicaid recipients, and carry a substantial comorbidity burden. Finally, hospitals with higher sepsis case volume appear to be at greater risk for sepsis readmissions. Our findings should raise the awareness of clinicians, administrators, and policy makers that as medical advances continue to improve sepsis survival, hospital readmissions will be a prevalent problem with substantial health and economic consequences. Future efforts toward readmission prediction modeling and the development of targeted interventions for high-risk individuals will be critical endeavors.
